That's essential, since the way a protein in the body folds figures out if a pharmaceutical will have the ability to bind to that protein and work. Simply put, we need to understand how these proteins fold if we desire a drug to work. Historically, this has actually been an experimental procedure (white house). Now, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it a lot easier to develop drugs that do what they're designed to do. This was an advancement nearly no one saw. However it's going to have extensive implications for treating illness. I forecast that Alpha, Fold will be 98% accurate by the end of 2021.
And, of course, there will be a lot of investment opportunities in this area, too. Shifting topics It's going to be an excellent year for bitcoin. I'm bullish on it in 2021 (biotech stocks). That stated, I still think bitcoin will continue to be unpredictable. We're close to all-time highs. I wouldn't be surprised if it pulled back maybe considerably before going greater - korean actress. I've been covering bitcoin for a long time now. One of the very first research study reports I ever released was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that preliminary recommendation, I titled my report "What's the Big Deal With Bitcoin?" That shows you where the discussion was at the time. We were mainly informing readers. However that's not the big concern anymore. Now we're seeing institutional money lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, niche enterprise. Mass, Mutual is a relied on 170-year-old institution. So believe about that. In 5 years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
Which's a big reason I'm bullish on it this year. last year. Regards, Jeff Brown, Editor, The Bleeding Edge I have a perk forecast 2020 was a record year for IPOs. 552 U.S. business went public the most in more than 20 years. These business raised an overall of $172 billion. That's an all-time high beating the previous yearly record by 43%. I predict 2021 will be another record year in IPOs. There are so lots of terrific personal companies on the verge of hitting the general public markets And I have actually been working on a new way for you to invest even before these companies go public.
This opportunity has actually been constructing over the last couple of years. I can't wait to tell you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to discover out all the information. Go right here to book your area free of charge.
Emma Walsh here, managing editor of the Journal. Routine Diary readers know that tech isn't our normal beat (the legacy report predictions). And when it comes to tech investing, we leave it to the experts. Luckily, we have a number of such experts in our Rolodex. Our colleague Jeff Brown will be familiar to our longtime readers. He is one of the most accomplished tech investing professionals we know (jeff brown biotech pick). In truth, he had several triple-digit returns in his Brownstone Research portfolios in 2015. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to have a look at the big photo and predict what's simply around the corner.
That includes things like 5G networks, biotech, synthetic intelligence, and far more. These patterns are experiencing exponential growth and producing incredible chances for financiers. I wish to make certain all our readers are prepared for what's next. And with that in mind, let me draw the photo of what I see coming in the next 12 months Our new 5G (fifth-generation) cordless networks are a subject I have actually been covering for years now. melania trump. However in spite of what numerous readers may think, this is a trend that's simply starting. Although the COVID-19 pandemic disrupted supply chains last year, an impressive 250 million 5G-enabled devices were still offered.
And all of this ultimately caused Apple postponing the release of the 5G-enabled i, Phone 12 by two months (united arab emirates). Losing two months of manufacturing and sales truly affects how lots of 5G devices are offered in the calendar year. When you think about all of that, offering 250 million units is impressive. More importantly, the delays brought on by the pandemic developed a lots of bottled-up demand. Which demand is now going to be pushed into 2021. In truth, I predict that more than 500 million 5G devices will be shipped in 2021 - first lady. And that's not my only 5G forecast When I've spoken about 5G in the past, I've explained its 3 different phases.
In Phase Two, 5G gadgets go on sale. 5G phones and other products begin to reach consumers. And in Stage 3, 5G services start to be provided (jeff brown 2021 stock predictions). That's when we begin to see applications operating on 5G networks. Think of things like massive multiplayer video games over a mobile phone. That's not possible with 4G. It will be with 5G. And my 2nd 5G forecast for 2021 is that we will start Stage Three by this summer. This starts something of a virtuous cycle: Many individuals don't actually care about the technology. However they will care if there are amazing applications that can only be accessed with a 5G phone.
That leads to more 5G apps being established. In reality, 5G is going to open a suite of amazing applications: self-driving cars and trucks, the Internet of Things, robotic surgery, and more. All of these technologies need 5G. The investment chances moving forward will be enormous. Stepping far from 5G, the next essential innovation I predict in 2021 is CRISPR hereditary editing. CRISPR represents "clustered frequently interspaced brief palindromic repeat." It's a mouthful. But it's one of the most interesting developments in biotechnology. At a high level, CRISPR is an innovation that can modify our genetic makeup as if it were software.
The program can crash or not work properly. CRISPR uses a comparable idea but with our genetic code. "Typos" in our genome can lead to illness. CRISPR can fix these "typos." For many years, CRISPR was primarily a specific niche innovation that wasn't well comprehended. And throughout that time, there were actually just three business running in this area. But things are altering. CRISPR is no longer just theoretical. We're seeing real outcomes. We're treating diseases and seeing that this technology simply works. And as an outcome, a "2nd crop" of early-stage CRISPR companies is going public and delivering unbelievable returns. This whole industry is efficiently a greenfield opportunity.
There's room for lots of business to exist in this area. tech stock. And there will be more. That's my forecast for CRISPR in 2021. I anticipate that two or 3 more hereditary modifying companies will hold their IPOs. Sticking with biotechnology, we are seeing amazing things happening at the merging of biotech and synthetic intelligence (AI). Google's AI subsidiary, Deep, Mind, simply announced at the end of 2020 that its latest Alpha, Fold software can precisely anticipate the folding of a protein based entirely on its amino acid sequence with 92. 4% accuracy. That's important since the way a protein in the body folds determines if a pharmaceutical will have the ability to bind to that protein and be effective.
Historically, this has been an experimental process. And now, Alpha, Fold can anticipate protein folding with 92. 4% precision. That's going to make it a lot easier to create drugs that do what they're designed to do. And here's my next forecast. I predict that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not just one however several drug therapies produced utilizing this innovation. This was among those developments that almost nobody noticed. But it's going to have extensive ramifications for curing disease. And, of course, there will be lots of financial investment opportunities in this space, too.
It's going to be an excellent year for bitcoin. I'm bullish on it in 2021. That said, I still think bitcoin will continue to be volatile. We're close to all-time highs. I wouldn't be surprised if it pulled back perhaps substantially prior to going higher. I have actually been covering bitcoin for a very long time now. Among the first research reports I ever released was on bitcoin - jeff brown 2021 predictions. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for anybody who followed my recommendation. But at the time of that preliminary recommendation, I entitled my report, "What's the Big Offer With Bitcoin?" That shows you where the discussion was at the time.
But no one is asking that concern any longer. Now, we're seeing institutional cash finally taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, specific niche business. artificial intelligence. Mass, Mutual is a 150-year-old organization. So consider that. In 5 years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a huge reason I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more benefit prediction In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown is worth about $27. 5 million and claims the info depends on date as of February 2021, but we could not independently verify this claim. Provided Jeff Brown's past, he likely has a substantial net worth, however we can't hammer down a precise figure at this minute. Brown is best known for his sage-like capability to choose winning technology stocks. He spent more than 25 years looking into innovation companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's comprehensive experience gives him an exceptional viewpoint on the marketplace. He's constantly on the hunt for brand-new opportunities, and he shares a lot of his finest choices in the Future Report.
That's full marks, but it's not ridiculously reasoned. Brown has an excellent credibility as a stock-picker, and he effectively anticipated some of the greatest economic occasions of the past 20 years. Although he does not appear to release his choices to the general public, the service's success is a direct indication of Brown's stock-picking expertise. Nobody on Wall Street gets it right whenever, however Jeff Brown's precise predictions have made him legions of devoted fans. That states a lot about his capability. The Near Future Report is released by Brownstone Research, a popular financial research publisher. Brownstone Research uses numerous research services with a wide range of expertises - jeff brown stock market prediction.
The company is likewise associated with Bonner & Partners, another well-respected research publisher - jeff brown biotech picks. On its site, Brownstone says its objective is to offer retail financiers with professional-grade research study: "For too long, the very best financial investment research has not been readily available to private financiers. It has been generally scheduled for financial investment banks, hedge funds, private equity, and high-net-worth clients. jeff brown stock predictions 2021. The objective of Brownstone Research is to make that type of proprietary research study available to any investors aiming to acquire an edge in the marketplaces. The objective is simple to deliver unique and rewarding investment research study discovered nowhere else." -Brownstone Research study website excerpt from the Jeff Brown is the creator of Brownstone Research, and he also functions as the firm's Chief Investment Analyst.
With Brown assisting the ship, Brownstone Research is a powerhouse publisher with lots to offer its customers. After decades of steady success at the helm of top-tier business like Tesla and Space, X, Elon Musk is a home name throughout many of America. If you understand even a little bit about the marketplace, you know that he has a track record as a King Midas of sorts. jeff brown top biotech 2020. Everything he touches turns to gold! Jeff is aware of Elon Musk's executive prowess, so he constantly has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next big job.
In reality, Brown believes S.A.V. jeff brown stock predictions 2021. might be "the biggest pattern of the 2020s, and he's not alone. Take a look at these quotes from other popular S.A.V. bulls: Elon's next huge act will be marrying two cutting-edge technologies: synthetic intelligence and electrical cars and trucks. Musk hopes the mix will assist him develop the very first fully-autonomous, self-driving vehicles ever. It's nothing brief of the automotive market's Holy Grail. As you know, electrical vehicles and self-driving car stocks have actually been substantial this year, but the Wall Street device has been big on buzz without much tangible outcome. Regardless of an extreme increase in competitors over the previous few years, Brown still thinks Musk has the very best opportunity of putting it all together.
tech could be the magic string that ties all of it together. S.A.V. stands for Shared Autonomous Vehicle, and it might be the future of transport. Essentially, this innovation would allow you to lease your car as a self-governing, self-driving taxi when you're not using it. You merely get out of the cars and truck and press a button on an app that informs the vehicle to "join the fleet." Next thing you understand, you're unwinding on your sofa while your cars and truck shuttles ride-sharers around town. Best of all, you get to keep a significant chunk of the earnings. It sounds ridiculous, but it could be closed than you believe.